Tyrosine kinase inhibitor treatments in patients with metastatic thyroid carcinomas: a retrospective study of the TUTHYREF network. [electronic resource]
Producer: 20140430Description: 575-82 p. digitalISSN:- 1479-683X
- Adenocarcinoma -- drug therapy
- Adenocarcinoma, Follicular -- drug therapy
- Adenoma, Oxyphilic
- Adult
- Aged
- Antineoplastic Agents -- therapeutic use
- Bone Neoplasms -- drug therapy
- Carcinoma -- drug therapy
- Carcinoma, Neuroendocrine
- Carcinoma, Papillary
- Disease-Free Survival
- Female
- Humans
- Indoles -- therapeutic use
- Liver Neoplasms -- drug therapy
- Lung Neoplasms -- drug therapy
- Lymphatic Metastasis
- Male
- Middle Aged
- Niacinamide -- analogs & derivatives
- Phenylurea Compounds -- therapeutic use
- Piperidines -- therapeutic use
- Pleural Neoplasms -- drug therapy
- Protein-Tyrosine Kinases -- antagonists & inhibitors
- Pyrroles -- therapeutic use
- Quinazolines -- therapeutic use
- Retrospective Studies
- Sorafenib
- Sunitinib
- Thyroid Cancer, Papillary
- Thyroid Neoplasms -- drug therapy
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Observational Study
There are no comments on this title.
Log in to your account to post a comment.